Immunotoxicity Considerations for Next Generation Cancer Nanomedicines

Abstract Although interest and funding in nanotechnology for oncological applications is thriving, translating these novel therapeutics through the earliest stages of preclinical assessment remains challenging. Upon intravenous administration, nanomaterials interact with constituents of the blood in...

Full description

Bibliographic Details
Main Authors: Gary Hannon, Joanne Lysaght, Neill J. Liptrott, Adriele Prina‐Mello
Format: Article
Language:English
Published: Wiley 2019-10-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.201900133